Successfully implementing pharmacogenomics into routine clinical practice requires an
efficient process to order genetic tests and report the results to clinicians and patients. Lack …

Introduction Reporting and sharing pharmacogenetic test results across clinical laboratories
and electronic health records is a crucial step toward the implementation of clinical …

The clinical implementation of pharmacogenetic biomarkers continues to grow as new
genetic variants associated with drug outcomes are discovered and validated. The number …

The slow rate at which pharmacogenetic tests are being adopted in clinical practice is partly
due to the lack of specific guidelines on how to adjust medications on the basis of the …

Pharmacogenomic testing interrogates germline sequence variants implicated in
interindividual drug response variability to infer a drug response phenotype and to guide …

One of the initial steps for implementing pharmacogenomics into routine patient care is
selecting an appropriate clinical laboratory to perform the testing. With the rapid advances in …

The delivery of more personalized medicinecould be accelerated by addressing the
substantial differences in the level of evidence required for the inclusion of pharmacogenetic …

Recent large-scale genetic-based studies have transformed the field of pharmacogenetics to
identify, characterize and leverage genetic information to inform patient care. Genetic testing …

Abstract The Clinical Pharmacogenetics Implementation Consortium (CPIC) publishes
genotype-based drug guidelines to help clinicians understand how available genetic test …

Purpose The current state of pharmacogenetic data curation and dissemination is described,
and evidence-based resources for applying pharmacogenetic data in clinical practice are …